ENCE CHUCK (Chief Financial Officer) purchased 587.5% of their position (228.96K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $103.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/20/2025ACC: 0001213900-25-046086
Officer· Chief Financial Officer
Since Jul 2019
+228.96K
Net shares
Net buyer
$103.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
228.96K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+228.96K
Price / share
$0.45
Trade value
$103.33K
% of position
587.5%
5/16/2025
38.97K→267.93K
Total
Net shares
+228.96K
Net value
$103.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2025 | P · Purchase | +228.96K | $0.45 | $103.33K | 587.5% | 38.97K | 267.93K |
| Total | +228.96K | $103.33K | ||||||
Derivative Transactions0
No derivative transactions reported